Biochemical changes in the serum of patients with chronic toxigenic mold exposures: a risk factor for multiple renal

Ebere Anyanwu1, Andrew W Campbell, Aristo Vojdani

  • 1Neurosciences Research, Cahers Inc., Conroe, TX, USA. ebereanyanwu@msn.com

Thescientificworldjournal
|November 13, 2003
PubMed

Insights

Chronic exposure to toxic molds is linked to biochemical abnormalities and increased risk of kidney disorders. This pilot study highlights potential renal complications in individuals with mycosis due to indoor mold exposure.

Area of Science:

  • Environmental Health
  • Biochemistry
  • Nephrology

Background:

  • Chronic mycosis, often linked to indoor environmental exposures like toxic molds, can manifest with diverse symptoms.
  • Understanding the biochemical underpinnings of mycosis is crucial for identifying associated health risks, particularly renal complications.

Purpose of the Study:

  • To analyze serum biochemical abnormalities in patients with chronic mycosis.
  • To investigate the association between these biochemical changes and the risk of developing multiple renal disorders.

Main Methods:

  • A pilot study involving 10 patients with chronic mycosis and 10 healthy controls.
  • Biochemical analysis of blood samples using methods including enzyme-linked immunoabsorbent assay (ELISA).

Main Results:

  • Patients exhibited abnormal concentrations of creatinine, uric acid, phosphorus, alkaline phosphatase, cholesterol, LDH, SGOT/AST, neutrophils, lymphocytes, T3, IgG, and IgA compared to controls.
  • These biochemical abnormalities were consistent with multiple renal disorders.
  • Common symptoms reported by patients included headaches, respiratory issues, allergies, memory loss, skin rashes, blurred vision, fatigue, and runny nose.

Conclusions:

  • Chronic exposure to indoor toxic molds is associated with significant biochemical abnormalities.
  • These findings suggest a strong link between chronic mycosis and indicators of renal dysfunction.
  • Individuals exposed to indoor molds may be at risk for multiple renal complications, warranting further investigation.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...